Bariatric Surgery

Many midlife women experience hypoactive sexual desire disorder, which can impact both relationships and mental health, but two FDA approved treatments are available, according to a speaker at the Annual Meeting of The Menopause Society.

Adults with obesity who underwent bariatric surgery were less likely to develop pancreatic cancer than those who with obesity who did not have bariatric surgery, researchers reported.

Prepregnancy bariatric surgery was linked to lower risks for gestational hypertension, large for gestational age infants and gestational diabetes but increased risks for preterm birth and small for gestational age infants, data show.

Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management, a speaker reported.

Bariatric surgery did not reduce risk for obesity-related cancer or cardiovascular disease compared with nonoperative treatment among adults aged at least 60 years, according to results of a population-based cohort study.

Obesity accounts for much of the risk for primary hypertension, and a treatment plan that could address both issues could substantially reduce a person’s underlying risk for cardiovascular disease and other complications.

Both obesity pharmacotherapy and bariatric surgery offer paths to substantial weight loss for people who struggle with excess weight, and new data suggest there is also an additional bonus benefit for many — a sustained reduction in blood pressure.

Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.